Search

Author/Creator Vijayakrishnan, Balakumar

1. CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity. Issue 2 (10th September 2020)

Authors:
Zammarchi, Francesca; Havenith, Karin; Bertelli, Francois; Vijayakrishnan, Balakumar; Chivers, Simon; van Berkel, Patrick H
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TR1801‐ADC: a highly potent cMet antibody–drug conjugate with high activity in patient‐derived xenograft models of solid tumors. Issue 1 (3rd December 2019)

Authors:
Gymnopoulos, Marco; Betancourt, Oscar; Blot, Vincent; Fujita, Ryo; Galvan, Diana; Lieuw, Vincent; Nguyen, Sophie; Snedden, Jeanette; Stewart, Christine; Villicana, Jose; Wojciak, Jon; Wong, Eley; Pardo, Raul; Patel, Neki; D'Hooge, Francois; Vijayakrishnan, Balakumar; Barry, Conor; Hartley, John A...
Journal:
Molecular oncology
Issue:
Volume 14:Issue 1(2020)
Page Start:
54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗